List of Excipients in API dopamine hydrochloride
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing dopamine hydrochloride
Excipients in ANDA-approved (generic) drugs containing dopamine hydrochloride
Detailed excipient profiles for dopamine hydrochloride
Excipient focus: ANHYDROUS CITRIC ACID
dopamine hydrochloride drug variants containing ANHYDROUS CITRIC ACID
dopamine hydrochloride drug variants not containing ANHYDROUS CITRIC ACID
Excipient focus: CITRIC ACID ACETATE
dopamine hydrochloride drug variants containing CITRIC ACID ACETATE
dopamine hydrochloride drug variants not containing CITRIC ACID ACETATE
Excipient focus: DEXTROSE MONOHYDRATE
dopamine hydrochloride drug variants containing DEXTROSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Baxter Healthcare Corporation | dopamine hydrochloride | 0338-1005 |
| HF Acquisition Co LLC DBA HealthFirst | dopamine hydrochloride | 51662-1316 |
| Hospira Inc | dopamine hydrochloride in dextrose | 0409-7808 |
| Hospira Inc | dopamine hydrochloride in dextrose | 0409-7809 |
| >Company | >Ingredient | >NDC |
dopamine hydrochloride drug variants not containing DEXTROSE MONOHYDRATE
Excipient focus: HYDROCHLORIC ACID
dopamine hydrochloride drug variants containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Baxter Healthcare Corporation | dopamine hydrochloride | 0338-1005 |
| HF Acquisition Co LLC DBA HealthFirst | dopamine hydrochloride | 51662-1316 |
| Hospira Inc | dopamine hydrochloride in dextrose | 0409-7808 |
| Hospira Inc | dopamine hydrochloride in dextrose | 0409-7809 |
| >Company | >Ingredient | >NDC |
dopamine hydrochloride drug variants not containing HYDROCHLORIC ACID
Excipient focus: SODIUM BISULFITE
dopamine hydrochloride drug variants containing SODIUM BISULFITE
| Company | Ingredient | NDC |
|---|---|---|
| Baxter Healthcare Corporation | dopamine hydrochloride | 0338-1005 |
| >Company | >Ingredient | >NDC |
dopamine hydrochloride drug variants not containing SODIUM BISULFITE
Excipient focus: SODIUM CITRATE
dopamine hydrochloride drug variants containing SODIUM CITRATE
dopamine hydrochloride drug variants not containing SODIUM CITRATE
Excipient focus: SODIUM HYDROXIDE
dopamine hydrochloride drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| HF Acquisition Co LLC DBA HealthFirst | dopamine hydrochloride | 51662-1316 |
| Hospira Inc | dopamine hydrochloride in dextrose | 0409-7808 |
| Hospira Inc | dopamine hydrochloride in dextrose | 0409-7809 |
| >Company | >Ingredient | >NDC |
dopamine hydrochloride drug variants not containing SODIUM HYDROXIDE
Excipient focus: SODIUM METABISULFITE
dopamine hydrochloride drug variants containing SODIUM METABISULFITE
dopamine hydrochloride drug variants not containing SODIUM METABISULFITE
| Company | Ingredient | NDC |
|---|---|---|
| Baxter Healthcare Corporation | dopamine hydrochloride | 0338-1005 |
| >Company | >Ingredient | >NDC |
Excipient focus: TRISODIUM CITRATE DIHYDRATE
dopamine hydrochloride drug variants containing TRISODIUM CITRATE DIHYDRATE
dopamine hydrochloride drug variants not containing TRISODIUM CITRATE DIHYDRATE
Excipient focus: WATER
dopamine hydrochloride drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Baxter Healthcare Corporation | dopamine hydrochloride | 0338-1005 |
| HF Acquisition Co LLC DBA HealthFirst | dopamine hydrochloride | 51662-1316 |
| Hospira Inc | dopamine hydrochloride in dextrose | 0409-7808 |
| Hospira Inc | dopamine hydrochloride in dextrose | 0409-7809 |
| >Company | >Ingredient | >NDC |
dopamine hydrochloride drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
